-
Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study
-
Adel Hussein Elduma, Mohammad Ali Mansournia, Abbas Rahimi Foroushani, Hamdan Mustafa Hamdan Ali, Asrar M A Salam Elegail, Asma Elsony, Kourosh Holakouie-Naieni
-
Epidemiol Health. 2019;41:e2019014. Published online April 20, 2019
-
DOI: https://doi.org/10.4178/epih.e2019014
-
-
16,476
View
-
602
Download
-
13
Web of Science
-
15
Crossref
-
 Abstract
 PDF
-
Abstract
OBJECTIVES
The emergence of multidrug-resistant tuberculosis (MDR-TB) is a major challenge for the global control of tuberculosis (TB). The aim of this study was to determine the risk factors associated with MDR-TB in Sudan.
METHODS This case-control study was conducted from May 2017 to February 2019. Patients newly diagnosed with MDR-TB were selected as cases, and controls were selected from TB patients who responded to first-line anti-TB drugs. A questionnaire was designed and used to collect data from study participants. Logistic regression was used to evaluate associations between risk factors and MDR-TB infection. The best multivariate model was selected based on the likelihood ratio test.
RESULTS A total of 430 cases and 860 controls were selected for this study. A history of previous TB treatment (adjusted odds ratio [aOR], 54.85; 95% confidence interval [CI], 30.48 to 98.69) was strongly associated with MDR-TB infection. We identified interruption of TB treatment (aOR, 7.62; 95% CI, 3.16 to 18.34), contact with MDR-TB patients (aOR, 5.40; 95% CI, 2.69 to 10.74), lower body weight (aOR, 0.89; 95% CI, 0.87 to 0.91), and water pipe smoking (aOR, 3.23; 95% CI, 1.73 to 6.04) as factors associated with MDR-TB infection.
CONCLUSIONS Previous TB treatment and interruption of TB treatment were found to be the main predictors of MDR-TB. Additionally, this study found that contact with MDR-TB patients and water pipe smoking were associated with MDR-TB infection in Sudan. More efforts are required to decrease the rate of treatment interruption, to strengthen patients’ adherence to treatment, and to reduce contact with MDR-TB patients.
-
Summary
-
Citations
Citations to this article as recorded by  - Assessment of risk factors associated with drug-resistant tuberculosis in pulmonary tuberculosis patients
Chanda Vyawahare, Sahjid Mukhida, Sameena Khan, Nageswari R. Gandham, Sriram Kannuri, Shalini Bhaumik
Indian Journal of Tuberculosis.2024; 71: S44. CrossRef - Risk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in southern Ethiopia: a case-control study
Fantahun Admassu, Ermias Abera, Addisalem Gizachew, Tagesse Sedoro, Taye Gari
BMJ Open.2023; 13(1): e061836. CrossRef - The Targeted Maximum Likelihood estimation to estimate the causal effects of the previous tuberculosis treatment in Multidrug-resistant tuberculosis in Sudan
Adel Hussein Elduma, Kourosh Holakouie-Naieni, Amir Almasi-Hashiani, Abbas Rahimi Foroushani, Hamdan Mustafa Hamdan Ali, Muatsim Ahmed Mohammed Adam, Asma Elsony, Mohammad Ali Mansournia, Selvakumar Subbian
PLOS ONE.2023; 18(1): e0279976. CrossRef - Investigating Empirical evidence on the Epidemiology, Diagnosis and Bibliometric analysis of the 100 topmost cited publications on Tuberculosis Disease
Taha Hussein Musa, Lovel Fornah, Tosin Yinka Akintunde, Idriss Hussein Musa, Hassan Hussein Musa, Gabriel Maxwell Turay , Maram Abdulhakim Abdulkarem Al-sharai
PAN AFRICA SCIENCE JOURNAL.2023;[Epub] CrossRef - Distribution of multi-drug resistant tuberculosis in Ekiti and Ondo states, Nigeria
Olugbenga Enoch Olabiyi, Pius Abimbola Okiki, Mumuni Idowu Adarabioyo, Oludele Emmanuel Adebiyi, Olusola Emannuel Adegoke, Olubunmi Ebenezer Esan, Olayinka O. Idris, Toluwani Bosede Agunbiade
New Microbes and New Infections.2023; 55: 101192. CrossRef - Drug-resistant tuberculosis in Colombia, 2013-2018: Case-control study
Gloria Mercedes Puerto , Claudia Marcela Castro , Vivian Vanesa Rubio , Santiago Fadul, Fernando Montes
Biomédica.2023; 43(4): 447. CrossRef - The second national anti‐tuberculosis drug resistance survey in Tanzania, 2017–2018
Beatrice Kemilembe Mutayoba, Julia Ershova, Eligius Lyamuya, Michael Hoelscher, Norbert Heinrich, Andrew Martin Kilale, Nyagosya Segere Range, Benard James Ngowi, Nyanda Elias Ntinginya, Saidi Mwinjuma Mfaume, Emmanuel Nkiligi, Basra Doulla, Johnson Lyimo
Tropical Medicine & International Health.2022; 27(10): 891. CrossRef - Bacterial infections epidemiology and factors associated with multidrug resistance in the northern region of Ghana
Jean-Pierre Gnimatin, Enoch Weikem Weyori, Shimea M. Agossou, Martin Nyaaba Adokiya
Scientific Reports.2022;[Epub] CrossRef - A Comparative Study of Chest Computed Tomography Findings: 1030 Cases of Drug-Sensitive Tuberculosis versus 516 Cases of Drug-Resistant Tuberculosis
Nianlan Cheng, Shuo Wu, Xianli Luo, Chunyan Xu, Qin Lou, Jin Zhu, Lu You, Bangguo Li
Infection and Drug Resistance.2021; Volume 14: 1115. CrossRef - HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis
Zeeba Zahra Sultana, Farhana Ul Hoque, Joseph Beyene, Md. Akhlak-Ul-Islam, Md Hasinur Rahman Khan, Shakil Ahmed, Delwer Hossain Hawlader, Ahmed Hossain
BMC Infectious Diseases.2021;[Epub] CrossRef - Analysis of the Factors Leading to Causation of Multidrug Resistant Tuberculosis among Cases Registered under Revised National Tuberculosis Control Programme in East Sikkim – A Case Control Study
Forhad Akhtar Zaman, Vijay Kumar Mehta, Shraddha Deokota
Journal of Evidence Based Medicine and Healthcare.2021; 8(8): 440. CrossRef - Molecular Detection of Drug-Resistant Mycobacterium tuberculosis in Sputum Specimens from the New and Previously Treated Tuberculosis Cases at the National Reference Chest Diseases Laboratory in Lusaka, Zambia
DK Mumena, G Kwenda , CW Ngugi , AK Nyerere
Journal of Biomedical Research & Environmental Sciences.2021; 2(4): 232. CrossRef Prevalence of Tuberculosis by Automated GeneXpert Rifampicin Assay and Associated Risk Factors Among Presumptive Pulmonary Tuberculosis Patients at Ataye District Hospital, North East Ethiopia
Daniel Gebretsadik, Nuru Ahmed, Edosa Kebede, Miftah Mohammed, Melaku Ashagrie Belete
Infection and Drug Resistance.2020; Volume 13: 1507. CrossRefDeterminants of Drug-Resistant Tuberculosis in Southern Ethiopia: A Case–Control Study
Daniel Biru, Endrias Markos Woldesemayat
Infection and Drug Resistance.2020; Volume 13: 1823. CrossRef- The low cases reported in Sudan regarding a pandemic COVID-19 and Sudan’s Health system responding
Abdelhakam G Tamomh, Babiker Saad Almugadam, Ahmed Mohammed Elnour Elkhalifa
Journal of Microbiology & Experimentation.2020; 8(4): 136. CrossRef
|
KSE
